As of Apr 29
| +0.11 / +1.87%|
The 1 analysts offering 12-month price forecasts for Assembly Biosciences Inc have a median target of 6.50, with a high estimate of 6.50 and a low estimate of 6.50. The median estimate represents a +8.33% increase from the last price of 6.00.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.